Obstetrics Department, São Paulo Federal University, São Paulo, Brazil.
Acta Obstet Gynecol Scand. 2014 May;93(5):469-76. doi: 10.1111/aogs.12366.
To assess correlations between maternal serum levels of pro- and anti-angiogenic factors with uterine perfusion in women with early- compared with late-onset preeclampsia, and in healthy pregnant women.
Case-control study.
Antenatal care clinic located within a hospital (São Bernardo do Campo, Brazil).
We enrolled 54 preeclamptic and 54 healthy control women who were coming for routine ultrasound at 28-36 weeks' gestation.
All participants had uterine artery and umbilical Doppler studies and a blood sample to assess maternal serum levels of soluble fms-like tyrosine kinase-1, soluble endoglin, adiponectin and plasminogen activator inhibitor-1. All angiogenic factors were measured using enzyme-linked immunosorbent assay.
Levels of pro- and anti-angiogenic factors in maternal serum, and uterine artery Doppler findings.
Concentrations of soluble fms-like tyrosine kinase-1 and soluble endoglin were significantly higher in preeclamptic than control women (p < 0.0001 and p < 0.0001, respectively), especially in those with early-onset (<34 weeks) preeclampsia. These two anti-angiogenic mediators were significantly correlated with increased uterine artery Doppler in the preeclamptic women. Plasminogen activator inhibitor-1 levels were significantly higher in preeclampsia (p = 0.03) but unrelated to uterine artery resistance. Adiponectin levels were similar in cases and controls, independent of body mass index and unrelated to uterine artery resistance.
Preeclamptic patients have increased soluble fms-like tyrosine kinase-1 and soluble endoglin serum levels and this increase is directly correlated with uterine artery resistance, especially in those with early-onset preeclampsia.
评估早发型与晚发型子痫前期患者及健康孕妇的母体血清中促血管生成和抗血管生成因子与子宫灌注之间的相关性。
病例对照研究。
巴西圣贝尔纳多-杜坎普的一家医院的产前护理诊所。
我们招募了 54 例子痫前期患者和 54 例健康对照孕妇,她们在 28-36 周妊娠时常规进行超声检查。
所有参与者均进行子宫动脉和脐带动脉多普勒研究,并采集血样以评估母体血清可溶性 fms 样酪氨酸激酶-1、可溶性内皮糖蛋白、脂联素和纤溶酶原激活物抑制剂-1 水平。所有血管生成因子均采用酶联免疫吸附试验进行测量。
母体血清中促血管生成和抗血管生成因子的水平以及子宫动脉多普勒检查结果。
与对照组相比,早发型子痫前期患者(<34 周)的可溶性 fms 样酪氨酸激酶-1 和可溶性内皮糖蛋白浓度显著升高(p<0.0001 和 p<0.0001),这两种抗血管生成介质与子痫前期患者子宫动脉多普勒升高显著相关。纤溶酶原激活物抑制剂-1 水平在子痫前期患者中显著升高(p=0.03),但与子宫动脉阻力无关。脂联素水平在病例组和对照组中相似,与体质指数无关,与子宫动脉阻力无关。
子痫前期患者的血清可溶性 fms 样酪氨酸激酶-1 和可溶性内皮糖蛋白水平升高,这种升高与子宫动脉阻力直接相关,尤其是早发型子痫前期患者。